Residency · Austin, TX
Sponsored by University of Texas at Austin Dell Medical School
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
The Lancet. Neurology · 2023 · 218 citations · Yessar Hussain
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
The Lancet. Neurology · 2024 · 95 citations · Yessar Hussain
Trial of Intravenous Immune Globulin in Dermatomyositis.
The New England journal of medicine · 2022 · 163 citations · Yessar Hussain
Association of Brain Age, Lesion Volume, and Functional Outcome in Patients With Stroke.
Neurology · 2023 · 64 citations · Kristin Wong
A large, curated, open-source stroke neuroimaging dataset to improve lesion segmentation algorithms.
Scientific data · 2022 · 79 citations · Kristin Wong
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
Therapeutic advances in neurological disorders · 2024 · 35 citations · Yessar Hussain
The ENIGMA Stroke Recovery Working Group: Big data neuroimaging to study brain-behavior relationships after stroke.
Human brain mapping · 2022 · 70 citations · Kristin Wong
Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial.
The Lancet. Rheumatology · 2023 · 43 citations · Yessar Hussain